Faculty of Medicine, Oncology Institute of Vojvodina, Clinic for Surgical Oncology — Department of Gynecology, University of Novi Sad, Sremska Kamenica, AP Vojvodina, Serbia
[6] Gradoni L, Gaeta GB, Pellizzer G, Maisto A, Scalone A. Mediterranean visceral leishmaniasis in pregnancy. Scand J Infect Dis. 1994;26(5):627 http://dx.doi.org/10.3109/00365549409011824[Crossref]
[7] Bourée P, Bisaro F. Parasitic diseases and pregnancy. Rev Prat 2007;57:137–147 [PubMed]
[8] Mellor AL, Munn DH (2000) Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 18:367–391 http://dx.doi.org/10.1146/annurev.immunol.18.1.367[Crossref]
[9] Meinecke CK, Schottelius J, Oskam L, Fleischer B. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Pediatrics 1999;104:e65 http://dx.doi.org/10.1542/peds.104.5.e65[Crossref]
[10] Jurisic V, Stojacic-Djenic S, Colovic N, Konjevic G. The role of cytokine in regulation of the natural killer cell activity. Srp Arh Celok Lek. 2008;136(7–8):423–429 http://dx.doi.org/10.2298/SARH0808423J[Crossref]
[11] Zinchuk A, Nadraga A. Congenital visceral leishmaniasis in Ukraine: case report. Ann Trop Paediatr 2010;30:161–164 http://dx.doi.org/10.1179/146532810X12703902516400[WoS][Crossref]
[12] Pagliano P, Carannante N, Rossi M, Gramiccia M, Gradoni L, Faella FS, Gaeta GB. Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother. 2005 Feb;55(2):229–233 http://dx.doi.org/10.1093/jac/dkh538[Crossref]